Michael Aaron Kelly - Jun 4, 2025 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director
Signature
/s/ Ryan Brown, attorney-in-fact
Stock symbol
PRME
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/5/2025, 06:13 PM
Previous filing
Jun 3, 2025
Next filing
Jun 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Michael Aaron Director C/O PRIME MEDICINE, INC., 60 FIRST STREET, CAMBRIDGE /s/ Ryan Brown, attorney-in-fact 2025-06-04 0001769668

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +55K $0.00 55K Jun 4, 2025 Common Stock 55K $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2026 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Remarks:

Exhibit 24 - Power of Attorney